Carnitine palmitoyltransferase II deficiency, myopathic form (Q104470): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/93488909 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_93488909
Property / CURIE: CID11:ID_93488909 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_93488909
Property / Canary Token: dki-india-ID_93488909 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
16 August 2026
Timestamp+2026-08-16T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 16 August 2026 / rank
 
Normal rank

Latest revision as of 10:19, 17 August 2026

The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness.
Language Label Description Also known as
default for all languages
ID_93488909
    English
    Carnitine palmitoyltransferase II deficiency, myopathic form
    The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness.

      Statements

      CID11:ID_93488909
      0 references
      dki-india-ID_93488909
      0 references
      Concluído
      0 references
      16 August 2026
      0 references